Bank of New York Mellon
COGT icon

Bank of New York Mellon’s Cogent Biosciences COGT Stock Holding History

Bank of New York Mellon’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7M Buy
533,968
+161,172
+43% +$5.64M ﹤0.01% 1603
2026
Q1 		$14.3M Sell
372,796
-3,500
-0.9% -$129K ﹤0.01% 1719
2025
Q4 		$13.4M Buy
376,296
+13,280
+4% +$373K ﹤0.01% 1757
2025
Q3 		$5.21M Buy
363,016
+71,225
+24% +$844K ﹤0.01% 2288
2025
Q2 		$2.1M Buy
291,791
+35,191
+14% +$195K ﹤0.01% 2716
2025
Q1 		$1.54M Sell
256,600
-2,166
-0.8% -$17K ﹤0.01% 2809
2024
Q4 		$2.02M Sell
258,766
-4,812
-2% -$48K ﹤0.01% 2759
2024
Q3 		$2.85M Sell
263,578
-63,006
-19% -$613K ﹤0.01% 2585
2024
Q2 		$2.75M Buy
326,584
+45,770
+16% +$347K ﹤0.01% 2618
2024
Q1 		$1.89M Sell
280,814
-20,085
-7% -$124K ﹤0.01% 2791
2023
Q4 		$1.77M Buy
300,899
+12,692
+4% +$97.3K ﹤0.01% 2895
2023
Q3 		$2.81M Buy
288,207
+39,491
+16% +$468K ﹤0.01% 2612
2023
Q2 		$2.94M Buy
248,716
+28,822
+13% +$331K ﹤0.01% 2620
2023
Q1 		$2.37M Sell
219,894
-38,879
-15% -$497K ﹤0.01% 2704
2022
Q4 		$2.99M Buy
258,773
+4,946
+2% +$61.3K ﹤0.01% 2624
2022
Q3 		$3.79M Buy
+253,827
New +$3.48M ﹤0.01% 2447
2019
Q2 		– Sell
-13,251
Closed -$232K – 4223
2019
Q1 		$232K Buy
13,251
+1,689
+15% +$28.9K ﹤0.01% 3834
2018
Q4 		$204K Buy
11,562
+8,273
+252% +$245K ﹤0.01% 3845
2018
Q3 		$135K Buy
3,289
+213
+7% +$12K ﹤0.01% 3995
2018
Q2 		$177K Buy
+3,076
New +$148K ﹤0.01% 3928

Other funds holding COGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of New York Mellon's COGT Position: Q2 2026 in Review

Bank of New York Mellon increased its Cogent Biosciences (COGT) stake by 43% in Q2 2026, buying an estimated $5.64M and bringing the position to 533,968 shares worth $20.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Bank of New York Mellon first reported a position in COGT in Q2 2018 and has held it in 20 quarters since. 115 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Bank of New York Mellon held 533,968 shares of Cogent Biosciences worth $20.7M as of Q2 2026.
  • Bank of New York Mellon bought 161,172 Cogent Biosciences shares in Q2 2026, an estimated $5.64M.
  • Cogent Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1603 holding.
  • Bank of New York Mellon first reported a position in Cogent Biosciences in Q2 2018 and has held it in 20 quarters since.
  • 115 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.